Panthera Investment’s Pfizer PFE Stock Holding History

Panthera Investment’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-13,491	Closed	-$411K	–	68
2014 Q1	$411K	Buy	+13,491	New	+$402K	0.33%	38

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Panthera Investment's PFE Position: Q4 2014 in Review

Panthera Investment sold out of Pfizer (PFE) in Q4 2014, closing a stake of 2 shares — an estimated $1K sold.

Panthera Investment first reported a position in PFE in Q2 2014 and held it in 2 quarters. The position peaked at $272K in Q2 2014. 1,861 funds tracked by Wall St. Rank hold PFE as of Q4 2014.

Panthera Investment reported no remaining Pfizer position as of Q4 2014 after selling out during the quarter.
Panthera Investment sold 2 Pfizer shares in Q4 2014, an estimated $1K.
Panthera Investment first reported a position in Pfizer in Q2 2014 and held it in 2 quarters.
Panthera Investment's Pfizer position peaked at $272K in Q2 2014.
1,861 funds tracked by Wall St. Rank held Pfizer as of Q4 2014.

Based on Panthera Investment's 13F filing for Q4 2014, filed 18 Feb 2015.